{
  "trial_id": "NCT00044252",
  "overall_assessment": "likely_ineligible",
  "inclusion": [
    {
      "criterion": "Group A subjects will be 8 women between 18 and 45 years of age who have complex partial seizures with Type 1 catamenial seizure exacerbation as previously defined.",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Patients receiving antiepileptic drug therapy will continue on their medications.",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "All subjects must agree to use double barrier contraceptives, have an intrauterine device in place or practice abstinence during the course of the study.",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Patients will be recruited from the epilepsy patient population at the National Institutes of Health.",
      "label": "met",
      "evidence": "quote"
    }
  ],
  "exclusion": [
    {
      "criterion": "Any illness requiring chronic drug therapy other than antiepileptic drugs.",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "Use of tricyclic antidepressants within 4 weeks prior to randomization and/or anti-psychotic drugs within 2 weeks prior to randomization.",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "notes": "Patient has a history of epilepsy, CHF, depression. He is currently on Dilantin and phenobarbital. The patient's seizures are likely due to anoxic brain injury at birth.",
  "_meta": {
    "topic_id": "9",
    "trial_id": "NCT00044252",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}